Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours [NA]

View source ↗

Summary

This clinical trial update announces that GT307 Injection, an autologous tumor-infiltrating lymphocyte therapy, is being studied for solid tumors and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• GT307 Injection (autologous tumor-infiltrating lymphocytes)

Snippet

Sponsor: Grit Biotechnology | Conditions: Solid Tumor, Adult | NA | Status: RECRUITING